Compare Southwest Airlines Co (LUV) vs McKesson Corporation (MCK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Southwest Airlines Co vs McKesson Corporation — how do they compare? Southwest Airlines Co trades at $48.69 (market cap $23.63B), while McKesson Corporation trades at $832.45 (market cap $97.35B). The key difference: McKesson Corporation is far larger — about 4.1× Southwest Airlines Co's market cap, and Southwest Airlines Co pays the higher dividend (1.49%). Which is the better fit depends on your goals.
| LUV | MCK | |
|---|---|---|
Market Cap | $23.63B | $97.35B |
Sector | Industrials | Health |
52-Week High | $54.80 | $995.69 |
52-Week Low | $29.06 | $659.01 |
Enterprise Value | $26.70B | $101.98B |
Dividend Yield | 1.49% | 0.39% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Southwest Airlines (LUV) trades at $48.69, up 1.27% today, with a neutral technical signal. The stock shows mixed earnings results, beating estimates in Q3 and Q4 2025 but missing in Q1 2026, with Q2 2026 results pending. Revenue grew to $28.06B in 2025, though net income margin declined to 1.57%. Analyst consensus is a Buy with a $52.47 price target, indicating potential upside. Recent news highlights Q2 earnings anticipation and sector-wide factors like fuel costs and travel demand.
The outlook for LUV is cautiously optimistic, driven by resilient travel demand and cost management efforts. Key opportunities include earnings growth potential and favorable analyst targets. Risks involve fuel price volatility, competitive pressures, and execution challenges. Investors should weigh strong institutional interest against macroeconomic headwinds affecting the airline industry.
McKesson (MCK) trades at $828.84, down 1.49% on the day, with a bullish technical outlook supported by moving averages and key support at $826. The company shows strong revenue growth, reaching $359.05B in 2025, and has beaten EPS estimates for three consecutive quarters. Analyst sentiment is overwhelmingly positive with 24 buy ratings and a consensus price target of $932.83, indicating 12.5% upside potential.
The outlook for MCK remains favorable due to consistent earnings beats, robust cash flow generation, and leadership in healthcare distribution. Risks include thin profit margins (1.18% net margin) and high liabilities relative to equity. Investors should focus on execution in specialty pharma and oncology services as key growth drivers amid competitive and regulatory pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Southwest Airlines Co
Southwest Airlines is the largest domestic carrier in the United States, as measured by the number of originating passengers boarded. Southwest operates over 700 aircraft in an all-Boeing 737 fleet. Despite expanding into longer routes and business travel, the airline still specializes in short-haul leisure flights, using a point-to-point network. Southwest operates a low-cost carrier business model.
Read more on LUV →About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →
